Showing results (71-80 of 432) with videos related to
Sort By:
Pageof 44
Neurology|August 1, 1991
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosisF Barkhof, O R Hommes, P Scheltens, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisoloneE L J Hoogervorst, C H Polman, F BarkhofNeuroimaging Clinics of North America|May 22, 2001
T1 hypointensities and axonal lossF Barkhof, G B Karas, M A van WalderveenNederlands Tijdschrift Voor Geneeskunde|August 26, 2004
[New diagnostic criteria for multiple sclerosis in clinical practice]B W Van Oosten, F Barkhof, C H PolmanRadiology|March 1, 1990
MR findings of cartilage invasion by laryngeal cancer: value in predicting outcome of radiation therapyJ A Castelijns, R P Golding, C van Schaik, et al.Neuroscience Letters|May 12, 2000
Unbiased whole-brain analysis of gray matter loss in Alzheimer's diseaseS A Rombouts, F Barkhof, M P Witter, et al.Neuropathology and Applied Neurobiology|March 27, 2004
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosisL Bö, J J G Geurts, R Ravid, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2008
The distribution of new enhancing lesion counts in multiple sclerosis: further explorationsIj van den Elskamp, Dl Knol, Bmj Uitdehaag, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 9, 2002
The role of MRI as a surrogate outcome measure in multiple sclerosisH F McFarland, F Barkhof, J Antel, et al.European Neurology|January 1, 1994
Evidence for atrophy of the corpus callosum in Alzheimer's diseaseP Vermersch, P Scheltens, F Barkhof, et al.Pageof 44